New cancer clinical trial: Mix Vaccine for Metastatic Kidney Cancer

Published on: November 29, 2017 at 10:00AM
Conditions:   Metastasis From Malignant Tumor of Kidney (Disorder);   Reaction - Mixed Vaccine
Intervention:   Biological: Mix vaccine
Sponsors:   Fuda Cancer Hospital, Guangzhou;   Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AcZpVv